Boston University School of Medicine, Cardiovascular Medicine, Department of Medicine, Boston Medical Center, Boston, MA 02118, USA.
N Engl J Med. 2013 Apr 18;368(16):1498-508. doi: 10.1056/NEJMoa1300610. Epub 2013 Mar 11.
Emergency surgery has become a rare event after percutaneous coronary intervention (PCI). Whether having cardiac-surgery services available on-site is essential for ensuring the best possible outcomes during and after PCI remains uncertain.
We enrolled patients with indications for nonemergency PCI who presented at hospitals in Massachusetts without on-site cardiac surgery and randomly assigned these patients, in a 3:1 ratio, to undergo PCI at that hospital or at a partner hospital that had cardiac surgery services available. A total of 10 hospitals without on-site cardiac surgery and 7 with on-site cardiac surgery participated. The coprimary end points were the rates of major adverse cardiac events--a composite of death, myocardial infarction, repeat revascularization, or stroke--at 30 days (safety end point) and at 12 months (effectiveness end point). The primary end points were analyzed according to the intention-to-treat principle and were tested with the use of multiplicative noninferiority margins of 1.5 (for safety) and 1.3 (for effectiveness).
A total of 3691 patients were randomly assigned to undergo PCI at a hospital without on-site cardiac surgery (2774 patients) or at a hospital with on-site cardiac surgery (917 patients). The rates of major adverse cardiac events were 9.5% in hospitals without on-site cardiac surgery and 9.4% in hospitals with on-site cardiac surgery at 30 days (relative risk, 1.00; 95% one-sided upper confidence limit, 1.22; P<0.001 for noninferiority) and 17.3% and 17.8%, respectively, at 12 months (relative risk, 0.98; 95% one-sided upper confidence limit, 1.13; P<0.001 for noninferiority). The rates of death, myocardial infarction, repeat revascularization, and stroke (the components of the primary end point) did not differ significantly between the groups at either time point.
Nonemergency PCI procedures performed at hospitals in Massachusetts without on-site surgical services were noninferior to procedures performed at hospitals with on-site surgical services with respect to the 30-day and 1-year rates of clinical events. (Funded by the participating hospitals without on-site cardiac surgery; MASS COM ClinicalTrials.gov number, NCT01116882.).
经皮冠状动脉介入治疗(PCI)后,急诊手术已变得罕见。在 PCI 期间和之后,现场是否有心脏手术服务对确保最佳结果是否至关重要,目前仍不确定。
我们纳入了在马萨诸塞州无现场心脏手术的医院就诊且有非紧急 PCI 适应证的患者,并以 3:1 的比例将这些患者随机分配至在该医院或有心脏手术服务的合作医院进行 PCI。共有 10 家无现场心脏手术的医院和 7 家有现场心脏手术的医院参与了研究。主要复合终点为 30 天(安全性终点)和 12 个月(有效性终点)时的主要不良心脏事件发生率——死亡、心肌梗死、再次血运重建或卒中等的复合终点。主要终点根据意向治疗原则进行分析,并使用 1.5(安全性)和 1.3(有效性)的乘法非劣效性边界进行检验。
共有 3691 名患者被随机分配至无现场心脏手术的医院(2774 名患者)或有现场心脏手术的医院(917 名患者)进行 PCI。无现场心脏手术的医院的主要不良心脏事件发生率为 9.5%,有现场心脏手术的医院为 9.4%(30 天的相对风险,1.00;95%单侧置信上限,1.22;非劣效性 P<0.001);12 个月时分别为 17.3%和 17.8%(相对风险,0.98;95%单侧置信上限,1.13;非劣效性 P<0.001)。两组在任何时间点的死亡、心肌梗死、再次血运重建和卒中(主要终点的组成部分)发生率均无显著差异。
在马萨诸塞州无现场手术服务的医院进行的非紧急 PCI 手术与在有现场手术服务的医院进行的手术在 30 天和 1 年的临床事件发生率方面非劣效。(由无现场心脏手术的参与医院资助;MASS COM ClinicalTrials.gov 编号,NCT01116882.)